Novel laudanosine dimers in which two laudanosine units are linked at C-2′ via a two or three-carbon linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed cross-coupling reactions (Mizoroki-Heck and Sonagashira reactions). In one example, a second three-carbon linker between the two isoquinoline N-atoms was also present leading to a novel macrocyclic ring system. Abstract: Novel laudanosine dimers in which two laudanosine units are linked at C-2' via a two or three-carbon linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed crosscoupling reactions (Mizoroki-Heck and Sonagashira reactions). In one example, a second three-carbon linker between the two isoquinoline N-atoms was also present leading to a novel macrocyclic ring system.
Introduction
Over two hundred bisbenzylisoquinoline alkaloids are known, the majority of these have one or two ether linkages between the two benzylisoquinoline moieties. 1 However, a number of these alkaloids have one of the linking ether bonds replaced by a biphenyl linkage. 2 The bisbenzylisoquinoline alkaloids show a range of interesting biological activities. Combined yield of 7 and 8 after column chromatography.
Base hydrolysis of rac/meso-7 and rac/meso-8 then gave rac/meso-9 and rac/meso-10, respectively (Scheme 2). A mixture of rac/meso-10 could be separated by preparative TLC. The stereochemistry of the individual isomers (whether rac or meso) however, could not be determined. (middle) and meso-7 (bottom). Rac/meso-7 was found to be insoluble in most solvents commonly employed for hydrogenation reactions (e.g. MeOH, EtOH, EtOAc) but was found to be partially soluble in acetone. Hydrogenation of rac/meso-7 in acetone resulted in the selective hydrogenation of the more soluble rac-7. After filtration of the catalyst, addition of methanol to the solution resulted in the precipitation of pure meso-7 in 30% yield while further purification of the mother liquors by column chromatography gave rac-11
in 35% yield (Scheme 3). Base hydrolysis of rac-11 then gave rac-12 in 95% yield (Scheme 3). This suggested that either the meso-or the rac-form of 18 had failed to form in this reaction or that either meso-or rac-18 was unstable to the reaction conditions and decomposed. A more likely explanation is that, because of the rigid alkyne tether, the two stereogenic centres in the isoquinoline ring are too remote to interact and thus the rac and meso forms of 18 have the same NMR chemical Base hydrolysis of rac-6 gave the secondary amine rac-20 in 90% yield (Scheme 6) which was condensed with succinic anhydride to give the amido acid rac-21 in 79% yield. An amide coupling reaction between the acid rac-21 and the 2'-bromobenzylisoquinoline derivative rac-22 24 gave the bisamide 23 as a mixture of the racemic and meso forms (Scheme 6). Attempts to convert rac/meso-23
to the target macrocyclic compound 3 using the Mizoroki-Heck reaction conditions developed in Schemes 2 and 4 were unsuccessful and resulted in a complex mixture of products. However, under the more traditional Heck reaction conditions (Pd(OAc) 2 , Ph 3 P, Et 3 N) the desired compound 3 was obtained in 15% yield. NMR analysis of 3 indicated that a single isomer was obtained, with only one set of separate resonances observed for each different isoquinoline moiety. We made no attempts to determine whether this was the racemic or meso form of 3. The NMR evidence suggested that either the meso-or the rac-form of 3 had failed to form in this reaction or that either meso-or rac forms of 23 or 3 were unstable to the reaction conditions and decomposed. 
Scheme 6
In summary, several novel laudanosine dimers in which two laudanosine units are linked at C-2' via a two or three-carbon linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed cross-coupling reactions. In one example, a second three-carbon linker between the two isoquinoline N-atoms was also present leading to the novel macrocyclic ring system 3. The biological activities of the N-deprotected bisisoquinoline compounds and the macrocyclic compound 3 will be reported in a separate publication. 
General method for Stille coupling reactions.
To a thick walled tube (sealed tube) containing a solution of the 2'-iodolaudanosine 4, PdCl 2 and PPh 3 in dry DMF under N 2 was added allyltributylstannane or tributylvinylstannane. The tube was sealed under a N 2 atmosphere and the mixture was stirred and heated at 110 0 C for 36 h. The solution was cooled, diluted with CH 2 Cl 2 and washed with H 2 O (4 x) and then brine. The CH 2 Cl 2 layer was evaporated and the residue was redissolved in CH 3 CN and extracted with hexane. The CH 3 CN layer was evaporated and the residue was purified by column chromatography (EtOAc: petrol (1 : 1)) (unless indicated otherwise) to afford the pure products.
(RS) 1-(2'-Ethenyl-4',5'-dimethoxyphenyl)methyl-2-trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline (5).
The 2'-iodolaudanosine derivative 4 (492 mg, 0.870 mmol), Pd(OAc) 2 (16 mg, 0.071 mmol), PPh 3 (43 mg, 0.174 mmol) and tributylvinylstannane (333 mg, 1.04 mmol, 0.29 mL) in dry DMF (10 mL) under N 2 was treated as described above using the general Stille coupling reaction conditions to afford a residue which was purified by column chromatography to afford 5 (352 mg, 87 %) as a yellow solid.
The yellow solid was recrystallized from EtOAc : petrol (1 : 1) and was a 95 : 5 mixture of rotamers. R f 0.48 (EtOAc: petrol (1 : 1) Compounds 7 and 8 were also prepared according to the conditions outlined in Table 1 under, essentially, the same conditions using the quantities of catalyst, base and additives shown in the Table. A small amount of (S,S)-7 (13 mg, 15 %) was obtained under the same Mizoroki-Heck coupling reaction conditions using a mixture of (S)-5 (60 mg, 0.105 mmol) and (S)-4 (80 mg, 0.171 mmol), Pd(OAc) 2 (3 mg, 0.013 mmol), DMG (27 mg, 0.258 mmol), NaOAc (21 mg, 0.258 mmol) and NMP (2 mL). A mixture of (S)-5 and (S)-4 (67 mg) was also recovered. Compound (S,S)-8 was also observed in the reaction, however, not in significant quantity or purity to characterize. Pd/C was filtered and the solvent was evaporated to give a crude mixture of meso-7 and rac-11. The crude mixture was dissolved in CH 2 Cl 2 (1 mL) and methanol (4 mL) was added slowly resulting in the precipitation of meso-7. The pure meso-7 (22 mg, 30 %) was filtered as a white solid. 
(1RS, 1`RS) and (R,
S
(R,S) 2-Trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4',5'-dimethoxy-2'-(2''-trimethylsilyl-2''-(trimethylsilylethynyl)ethenyl)phenyl)methylisoquinoline (16).
Compound 4 (300 mg, 0.530 mmol), PdCl 2 (4.5 mg, 0.027 mmol), PPh 3 (13.6 mg, 0.053 mmol) and CuI (10 mg, 0.053 mmol) were added to a dry flask under a N 2 atmosphere. Dry THF (45 mL) was added to the mixture followed by the addition of Et 3 N (161 mg, 1.59 mmol, 0.11 mL). 
(1RS, 1`RS) and (R,S) 2',2``-(1'',2''-Ethynediyl)-bis-[2-trifluoroacetyl-1,2,3,4-tetrahydro-

6,7-dimethoxy-1-(4',5'-dimethoxyphenyl)methyl]isoquinoline (18).
General method for N-TFA deprotection.
To a solution of the N-TFA protected amine in a mixture of CH 3 OH and H 2 O was added solid K 2 CO 3 .
The reaction mixture was stirred at rt for 18 h. The CH 3 OH was evaporated and the residue was dissolved in EtOAc. The solution was washed with H 2 O (3 x) and then brine and evaporated to give a yellow oil. The oil was purified by column chromatography (CH 3 OH : EtOAc: NH 3 (4 : 6 : 0.1)) (unless stated otherwise) to give the free amine. -[1,2,3,4-tetrahydro-6,7- 
(1RS and 1`RS) and (R,S) 2',2``-(1'',2''-Eth-(E)-enediyl)-bis
dimethoxy-1-(4',5'-dimethoxyphenyl)methyl]isoquinoline (9).
The N-TFA protected stilbene 7 (108 mg, 0.123 mmol), CH 3 OH (5 mL), H 2 O (0.6 mL) and K 2 CO 3 (89 mg, 0.641 mmol) were treated as described above using the general N-TFA deprotection reaction procedure except that the mixture was heated at 80 0 C for 3 d to give a yellow oil. The oil was purified by column chromatography to give 9 (36 mg, 41 %) as a yellow oil. Product 9 was a 55 : 45 mixture of meso-9 and rac-9. R f 0.07 (CH 3 OH : EtOAc (4 : 6) 1RS, 1`RS) and (R,S) 2',2``-(1,1-Ethenediyl)-bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4',5'- 
(
dimethoxyphenyl)methyl]isoquinoline (10).
Compound 8 (38 mg, 0.044 mmol), CH 3 OH (3 mL), H 2 O (0.6 mL) and K 2 CO 3 (30 mg, 0.218 mmol)
were treated as described above using the general N-TFA deprotection reaction procedure except that the reaction mixture was heated at 80 Hz, H7', H7``). 13 C NMR of the major diastereomer:  150.9 (C4', C4``), 148.5 (C5', C5``), 147. 
(1RS, 1`RS) and (R,S) 2',2``-(1'',2''-Ethanediyl)-bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4',5'-dimethoxyphenyl)methyl]isoquinoline (12).
Compound rac-11 (4 mg, 0.003 mmol), CH 3 OH (1 mL), H 2 O (0.5 mL) and K 2 CO 3 (12 mg, 0.085 mmol) was treated as described above using the general N-TFA deprotection reaction procedure to afford rac-12 (3 mg, 95 % yield) as a yellow oil without the need for further purification. R f 0.14 (DCM : EOAc : CH 3 OH : NH 3 (10 : 5 : 1 : 0.1) 
